Skip to main content
. 2022 Feb 25;54(2):194–205. doi: 10.1038/s12276-022-00735-x

Fig. 7. Schematic diagram showing the mechanism by which IGF2BP3 contributes to tumorigenesis and poor prognosis in AML through m6A RNA methylation.

Fig. 7

Model showing mechanism by which pro-oncogenic trigger may impair the cross-talk among m6A reader IGF2BP3, stabilize m6A-labeled genes and promote the abnormal accumulation of carcinogens (such as Myc, CEBPA, Bcl2, RCC2, etc.), thereby regulating the survival of leukemia cells and leading to AML progression.